BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30952561)

  • 1. Chest wall pain following lung stereotactic body radiation therapy using 48Gy in three fractions: A search for predictors.
    Albers J; Parker W; Kildea J; Pembroke C; Faria S
    Cancer Radiother; 2019 Apr; 23(2):98-103. PubMed ID: 30952561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.
    Woody NM; Videtic GM; Stephans KL; Djemil T; Kim Y; Xia P
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):427-34. PubMed ID: 22197087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.
    Mutter RW; Liu F; Abreu A; Yorke E; Jackson A; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1783-90. PubMed ID: 21868173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry.
    Coroller TP; Mak RH; Lewis JH; Baldini EH; Chen AB; Colson YL; Hacker FL; Hermann G; Kozono D; Mannarino E; Molodowitch C; Wee JO; Sher DJ; Killoran JH
    PLoS One; 2014; 9(4):e94859. PubMed ID: 24728448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.
    Murray L; Karakaya E; Hinsley S; Naisbitt M; Lilley J; Snee M; Clarke K; Musunuru HB; Ramasamy S; Turner R; Franks K
    Br J Radiol; 2016; 89(1058):20150628. PubMed ID: 26760508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Manyam BV; Videtic GMM; Verdecchia K; Reddy CA; Woody NM; Stephans KL
    Pract Radiat Oncol; 2019 Mar; 9(2):e187-e195. PubMed ID: 30529796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Chest Wall Toxicity During Long-term Follow Up After Thoracic Stereotactic Body Radiation Therapy.
    Chipko C; Ojwang J; Gharai LR; Deng X; Mukhopadhyay N; Weiss E
    Pract Radiat Oncol; 2019 May; 9(3):e338-e346. PubMed ID: 30731275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
    Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
    Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.
    Kim SS; Song SY; Kwak J; Ahn SD; Kim JH; Lee JS; Kim WS; Kim SW; Choi EK
    Lung Cancer; 2013 Feb; 79(2):161-6. PubMed ID: 23182662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy.
    Welsh J; Thomas J; Shah D; Allen PK; Wei X; Mitchell K; Gao S; Balter P; Komaki R; Chang JY
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):91-6. PubMed ID: 20542388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.
    Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
    J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
    Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
    J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain.
    Din SU; Williams EL; Jackson A; Rosenzweig KE; Wu AJ; Foster A; Yorke ED; Rimner A
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):418-24. PubMed ID: 26254680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
    Park Y; Kim HJ; Chang AR
    Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
    Thibault I; Chiang A; Erler D; Yeung L; Poon I; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):28-35. PubMed ID: 26129745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
    Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
    J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.